Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.45% | 166.93 | 0.7% | $1253.55m | |
| LLY | Eli Lilly & Co. | 0.18% | 311.43 | 1.1% | $814.08m | |
| BMY | Bristol-Myers Squibb Co. | -0.73% | 70.77 | 1.0% | $778.85m | |
| PFE | Pfizer Inc. | -1.10% | 44.08 | 0.9% | $769.71m | |
| ABBV | AbbVie, Inc. | 0.04% | 143.06 | 1.9% | $735.85m | |
| MRK | Merck & Co., Inc. | -0.81% | 86.80 | 0.7% | $691.58m | |
| AZN | AstraZeneca Plc | -3.07% | 54.58 | 1.0% | $397.16m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.95% | 200.78 | 8.2% | $207.03m | |
| NVS | Novartis AG | -1.47% | 76.01 | 0.2% | $201.13m | |
| GBT | Global Blood Therapeutics, Inc. | 0.03% | 67.99 | 5.4% | $199.71m | |
| GSK | GSK Plc | -2.13% | 29.37 | 0.3% | $192.16m | |
| NVO | Novo Nordisk A/S | -0.40% | 97.92 | 0.1% | $170.11m | |
| HZNP | Horizon Therapeutics Plc | 0.54% | 62.97 | 5.4% | $156.21m | |
| SGEN | Seagen Inc. | -0.96% | 139.20 | 5.7% | $152.48m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.42% | 108.19 | 12.4% | $128.76m |
Company Profile
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Hayward, CA.